The New England Biotech Association (NEBA) supports public policies that promote innovation and encourage economic development within the biotechnology and biopharmaceutical industry in New England.
NEBA encourages legislators and other key officials at the local, state, and federal level to adopt policies that:
Assure that patients have continued and open access to life-improving breakthrough biotechnology and biopharmaceutical medicines
Provide tax incentives for research and development, creation of high-skilled jobs, and the delivery of new and innovative therapies to patients for unmet medical needs
Increase collaboration and technology transfer between the biotechnology industry and academic institutions
Promote economic development and job growth in the biotechnology and life-science sector via expedited permitting, zoning changes, and other targeted incentives
Ensure continued innovation and investment in the biotech sector in New England by protecting patents and intellectual property
Support a strong educational foundation for the biotechnology industry in New England with increased resources and focus on quality math and science education
Create a qualified, sustainable employment base for biotechnology companies in New England through comprehensive job training and workforce development programs
The New England Biotech Association urges policy makers in New England to oppose measures harmful to the biotech industry such as: price controls of breakthrough medicines; onerous restrictions on educational & marketing practices of biotechnology companies; and risky importation of medicines not regulated and approved by the FDA.
